about
FXR is a molecular target for the effects of vertical sleeve gastrectomyUse of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease.Transplantation of non-visceral fat to the visceral cavity improves glucose tolerance in mice: investigation of hepatic lipids and insulin sensitivity.NHE1 deficiency in liver: implications for non-alcoholic fatty liver disease.High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities.Effect of guanylate cyclase-C activity on energy and glucose homeostasisRetrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: comparison of prophylactic oral ganciclovir and oral valganciclovir.Neurologic outcome of urea cycle disorder liver transplant recipients may be predicted by pretransplant neurological imaging.Isolated unilateral cytomegalovirus retinitis: a rare long-term complication after pediatric liver transplantation.Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats.Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON).A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery.Subcutaneous Adipose Tissue Transplantation in Diet-Induced Obese Mice Attenuates Metabolic Dysregulation While Removal Exacerbates It.Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study.MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched dietIL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice.Advances in the surgical treatment of morbid obesity.Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis.Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia.Prospective Assessment of Correlation between US Acoustic Radiation Force Impulse and MR Elastography in a Pediatric Population: Dispersion of US Shear-Wave Speed Measurement Matters.Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis.Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium.Rapid progression of NASH in childhood.Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis.Diabetes: the search for mechanisms underlying bariatric surgery.High prevalence of hepatitis B non-immunity in paediatric non-alcoholic fatty liver disease patients.Let the bile flow!Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner.The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice.Alpha 1-antitrypsin levels can differentiate allelic phenotypes.Relative elevations of serum alanine and aspartate aminotransferase in muscular dystrophy.Mesalamine-induced pneumonitis during therapy for chronic inflammatory bowel disease: a pediatric case report.Fibroblast growth factor 21 correlates with weight loss after vertical sleeve gastrectomy in adolescents.Incidental inflammatory adenoma with β-catenin activation in the setting of paediatric NASH.There's more under the nonalcoholic fatty liver disease umbrella than an elevated alanine aminotransferase level.The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Hepatic technetium-99m-mebrofenin iminodiacetate scans and serum gamma-glutamyl transpeptidase levels interpreted in series to differentiate between extrahepatic biliary atresia and neonatal hepatitis.
P50
Q28236848-178E643F-92AB-4741-9627-B22FC0A9CB8EQ30421930-01F40DD0-0B4B-4AF4-B66C-D985EECDBC7FQ33746692-B274FB57-586C-485B-9120-D3808220BDB7Q33954199-846A6077-126C-4BF4-B698-8D928787CFC9Q34023013-77AD94F0-FAC5-4B00-BF33-91B2C13330E1Q34178895-A82493C2-9166-4A1D-A407-C9525C6DABFDQ34393417-1CDEB387-4298-4F4F-AFCF-2E3E4CF2C268Q35785403-A0BF2FE7-830D-4A94-8369-1AFBFB917DF1Q35797975-B0EF7FC9-12E3-4A38-9E8C-7C9B6D9134CFQ36288302-F9974E37-9BDD-4944-AB66-090FEB70EE7FQ36486182-DA500146-98B6-4CBD-9964-415CF7416DF6Q36736464-4AA4A830-24AD-4CDE-B4E9-0EC5B034ED34Q36839983-F52B3E99-BE7B-4FCE-AAD6-0B1F3BA65DD1Q36946081-ABDAA2E9-E6FE-4AD6-BC8A-4271FE430111Q37058605-FC3DB6C5-7486-404D-9221-0F9EB85223D4Q37417603-B5B3070A-4C55-40CA-8205-DC0812E10CBDQ37476440-6731BE32-2E85-4CF4-B45E-03B83FB4BFD2Q37684723-A6F194F7-20E7-41DF-8DE7-E7C7678A71EAQ38054285-07F1107D-48B0-41D6-B653-E5708DF1A25CQ38516786-2F648E36-C548-4A4E-9A36-EB48B33E15C6Q38627620-02279042-E6E2-49A7-87D3-8E855989AC00Q38686646-1712C86C-E9D6-4F92-A524-D169E3101014Q38845009-6E14C933-4E95-45CB-80D1-751770ABC00AQ39251941-387BCD97-398A-4120-A714-765ECEF3EF7EQ40324567-DD138BD6-F477-4E4E-84B0-5EC5FAF0E3B3Q40864806-A6082B28-22E8-4B75-AC18-239D2DCEA401Q41252411-F2B30735-A4DB-443D-A3CC-0DE4FB1BE3F8Q41859691-06352EEB-34D6-4AB2-8DEB-7BFD56F64A0DQ42277796-C2CFBF2D-2D5D-4F43-B244-0941AEBA3B0EQ42821229-E4FA9D3F-EA49-42BC-89C1-72F309A42B92Q42873394-0F0FEDC5-B846-4BB1-BF06-0B51BE3AA0EAQ43094757-B135F62E-99EA-4E19-816A-F2A50298FA47Q45044638-3D6D769D-6256-4F54-8921-F65981D30D69Q46577499-024D1BAF-A7FE-45B2-BC8E-47FA6DF722F0Q46736360-7E9EBDBA-5C6D-4DAD-BAE2-E29D39F3DDBAQ47261474-C1FAEFF6-A601-4DFF-84A7-AA73E8C1288CQ47968606-B4EABDE5-61F5-44F0-BD82-9022B5D774D4Q48129743-AA2FDCEB-927B-4891-B6BD-22B484CBB61FQ50426718-163C2760-5797-4626-88C2-6F37279682B5Q52052661-8C7A21D8-376F-4ED8-A6A8-ABE7A5364C94
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rohit Kohli
@ast
Rohit Kohli
@en
Rohit Kohli
@es
Rohit Kohli
@nl
type
label
Rohit Kohli
@ast
Rohit Kohli
@en
Rohit Kohli
@es
Rohit Kohli
@nl
prefLabel
Rohit Kohli
@ast
Rohit Kohli
@en
Rohit Kohli
@es
Rohit Kohli
@nl
P106
P31
P4012
P496
0000-0002-0198-7703